Cullinan Oncology
CGEM
CGEM
142 hedge funds and large institutions have $471M invested in Cullinan Oncology in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
99% less call options, than puts
Call options by funds: $101K | Put options by funds: $7.55M
Holders
142
Holding in Top 10
4
Calls
$101K
Puts
$7.55M
Top Buyers
| 1 | +$8.92M | |
| 2 | +$1.32M | |
| 3 | +$1.03M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$832K |
| 5 |
VC
Voss Capital
Houston,
Texas
|
+$578K |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$7.42M | |
| 3 | -$2.05M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$1.82M |
| 5 |
Morgan Stanley
New York
|
-$1.81M |
